Onconetix, Inc.
Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $3.00
- 52-Week Range
- $2.76 – $1,610.00
- Market Cap
- $2.58M
- P/E (TTM)
- 0.00
- EPS (TTM)
- 3103.90
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- —
- PEG Ratio
- —
- Return on Equity
- —
- Return on Assets
- -24.93%
- Gross Margin
- 73.81%
- Operating Margin
- -1578.28%
- Profit Margin
- 0.00%
- Current Ratio
- 1.47
- Debt/Equity
- —
- Total Debt
- $105.07K
- Free Cash Flow
- $-19.31M
- Revenue Growth
- -66.10%
- Earnings Growth
- —
- Enterprise Value
- $-51.66K
Market Snapshot
About
Onconetix, Inc. develops oncology therapeutics focused on novel cancer treatments. The company works on targeted therapies and innovative drug candidates for various cancer types.